Recently, the research team of Professor Ye Bangtse of the State Key Laboratory of Bioreactor Engineering, ECUST, has made breakthrough progress in the design of DNA nanosystems and biomedical application research. The related research article was published in Journal of American Chemical Society with the title of “Nano-Biohybrid DNA Engager That Reprograms the T Cell Receptor”.

The research was conducted by Post-docatoral Candidate Ma Peiqiang, and Doctoral Candidates Liu Tianxian and Li Huadong, and the article is corresponding-authored by Professor Ye Bangtse and Professor Yin Bincheng. This research has been financially supported by the National Key Research and Development Plan, the National Natural Science Foundation of China, and the Shanghai Dawn Project.